AI for Drug Discovery Market is Set to Fly High in Years to Come

Advance Market Analytics published a new research publication on "AI for Drug Discovery Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the AI for Drug Discovery market was mainly driven by the increasing R&D spending across the world.

Some of the key players profiled in the study are:
Atomwise, Inc. (United States), Insilico Medicine (United States), BIOAGE (United States), Envisagenics (New York), Cloud Pharmaceuticals, Inc. (United States), Numerate (United States), NuMedii, Inc. (United States), BenevolentAI (United Kingdom), twoXAR, Incorporated (United States), Exscientia (United Kingdom).

Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/99822-global-ai-for-drug-discovery-market?utm_source=OpenPR&utm_medium=Suraj

Scope of the Report of AI for Drug Discovery
AI for drug discovery refers to the utilization of artificial intelligence (AI) and machine learning (ML) techniques to accelerate and optimize the process of discovering new pharmaceutical compounds. By analyzing vast amounts of biological, chemical, and clinical data, AI algorithms can identify potential drug candidates, predict their properties, and assess their efficacy and safety with unprecedented speed and accuracy. These technologies enable researchers to sift through immense datasets, identify patterns, and make predictions that would be challenging or impossible using traditional methods alone. AI for drug discovery encompasses various approaches, including virtual screening, de novo drug design, target identification, and optimization of lead compounds.

In March 18, 2024, NVIDIA today launched more than two dozen new microservices that allow healthcare enterprises worldwide to take advantage of the latest advances in generative AI from anywhere and on any cloud. The new suite of NVIDIA healthcare microservices includes optimized NVIDIA NIM AI models and workflows with industry-standard APIs, or application programming interfaces, to serve as building blocks for creating and deploying cloud-native applications.

The titled segments and sub-section of the market are illuminated below:
by Drug Type (Small Molecule, Large Molecules), Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others), Technology (Deep Learning, Machine Learning), End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes, Others)

Market Drivers:
High Adoption Due To AI Reduces Researches and Development Gap in the Drug Manufacturing Process
Growing Demand Due To Reduction in Price

Market Trends:
Upsurge In Capital of the R&D Activities for the Use of AI Technology
Growing Number of Cross-Industry Partnerships & Collaborations

Opportunities:
Huge Demand from Untapped Market
Rising Awareness about AI for Drug Discovery

What can be explored with the AI for Drug Discovery Market Study?
• Gain Market Understanding
• Identify Growth Opportunities
• Analyse and Measure the Global AI for Drug Discovery Market by Identifying Investment across various Industry Verticals
• Understand the Trends that will drive Future Changes in AI for Drug Discovery
• Understand the Competitive Scenarios
- Track Right Markets
- Identify the Right Verticals

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Have Any Questions Regarding Global AI for Drug Discovery Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/99822-global-ai-for-drug-discovery-market?utm_source=OpenPR&utm_medium=Suraj

Strategic Points Covered in Table of Content of Global AI for Drug Discovery Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the AI for Drug Discovery market
Chapter 2: Exclusive Summary - the basic information of the AI for Drug Discovery Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the AI for Drug Discovery
Chapter 4: Presenting the AI for Drug Discovery Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020
Chapter 6: Evaluating the leading manufacturers of the AI for Drug Discovery market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2027)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

finally, AI for Drug Discovery Market is a valuable source of guidance for individuals and companies.

Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/99822-global-ai-for-drug-discovery-market?utm_source=OpenPR&utm_medium=Suraj

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.

Contact US:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA - 08837
Phone: (+1 201 565 3262, +44 161 818 8166)
sales@advancemarketanalytics.com

About Author:
Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies' revenues.
Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enables clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

This release was published on openPR.